| --- | --- | --- | --- | |-------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | ICU Medical, Inc. Q3 2021 Conference Call | | | | | | | | | | Presentation | | | | Disclosures > Any statement concerning Management's expectation with respect to future results is a forward looking statement based upon the best information currently available to Management and assumptions Management believes are reasonable, but Management does not intend the statement to ...

ICU Medical, Inc. (NASDAQ:ICUI) Q3 2021 Earnings Conference Call November 3, 2021 4:30 AM ET Company Participants John Mills – Managing Partner Vivek Jain – Chairman and Chief Executive Officer Brian Bonnell – Chief Financial Officer Conference Call Participants Larry Solow – CJS Securities Matthew Mishan – Keybank Jayson Bedford – Raymond James Operator Good day, and welcome to the ICU Medical Incorporated Third Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode ...

ICU Medical, Inc. (NASDAQ:ICUI) ICU Medical Acquisition of Smiths Medical Division September 8, 2021 8:30 AM ET Company Participants John Mills - ICR, IR Vivek Jain - Chairman and CEO Brian Bonnell - Chief Financial Officer Christian Voigtlander - Chief Operating Officer Conference Call Participants Larry Solow - CJS Securities Matt Mishan - KeyBanc Jayson Bedford - Raymond James Operator Good day, and welcome to ICU Medical, Inc.'s conference call to discuss the acquisition of Smiths Medical division from ...

ICU Medical, Inc. (NASDAQ:ICUI) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants John Mills - ICR, IR Vivek Jain - Chairman and CEO Brian Bonnell - Chief Financial Officer Conference Call Participants Larry Solow - CJS Securities Matt Mishan - KeyBanc Jayson Bedford - Raymond James Operator Good day. And welcome to the ICU Medical, Inc. Q2 2021 Earnings Call. Today’s conference is being recorded. At this time, I’d like to turn the conference over to Mr. John Mills of ICR. Plea ...

| --- | --- | --- | --- | |-------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | ICU Medical, Inc. Q2 2021 Conference Call | | | | | Presentation | | | | | August 4, 2021 | | | | Disclosures > Any statement concerning Management's expectation with respect to future results is a forward looking statement based upon the best information currently available to Management and assumptions Management believes are reasonable, but Management does not intend t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to (Registrant's telephone number including area code) Commission File No.: 001-34634 Indicate by check mark whether the registrant (1) has filed all reports required t ...

ICU Medical, Inc. (NASDAQ:ICUI) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants John Mills – Managing Partner Vivek Jain – Chairman and Chief Executive Officer Brian Bonnell – Chief Financial Officer Conference Call Participants Matt Mishan – KeyBanc Jayson Bedford – Raymond James Pete Lukas – CJS Securities Operator Good day, and welcome to the ICU Medical, Inc.’s Q1 2021 Earnings Call. Today’s conference is being recorded. At this time, I will turn the conference over to Mr. J ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No.: 001-34634 ICU MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 33-0022692 (State or other jurisdiction of (I.R.S. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-34634 ICU MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 33-0022692 (State or other jurisdiction of incorporation or ...

ICU Medical, Inc. (NASDAQ:ICUI) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants John Mills - Managing Partner-ICR Vivek Jain - Chief Executive Officer & Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Matthew Mishan - KeyBanc Pete Lukas - CJS Securities Jayson Bedford - Raymond James Operator Good afternoon, ladies and gentlemen and welcome to the Fourth Quarter 2020 ICU Medical, Incorporated Earnings Conference Call. At this time, all partici ...